HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Levade, T. Articles by Courtoy, P. J. Search for Related Content PubMed PubMed Citation Articles by Levade, T. Articles by Courtoy, P. J. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol 37, 2525-2538, Copyright © 1996 by Lipid Research, Inc.

ARTICLES

In situ assay of acid sphingomyelinase and ceramidase based on LDL- mediated lysosomal targeting of ceramide-labeled sphingomyelin

T Levade, M Leruth, D Graber, A Moisand, S Vermeersch, R Salvayre and PJ Courtoy
Laboratoire de Biochimie, CJF INSERM 9206, Institut Louis Bugnard, C.H.U. Rangueil, Toulouse, France.

The activity of lysosomal sphingolipid hydrolases is usually estimated in vitro from complex assays on cell lysates under artificial conditions including the presence of detergents and substrate analogs. However, the measure of their effective activity in situ (i.e., in living cells) is necessary to understand the normal intracellular sphingolipid turnover. Moreover, their determination in cells from patients with genetic enzyme deficiencies represents a key parameter of the pathophysiology of sphingolipid storage disorders. In this report, we have developed a procedure for estimating the effective activity of lysosomal sphingomyelinase and ceramidase in situ. This procedure is based on the selective targeting to lysosomes of a natural substrate under physiological conditions of substrate influx. Epstein-Barr virus- transformed human lymphoid cells and human skin fibroblasts were incubated with purified human low density lipoproteins (LDL) containing [3H]ceramide-labeled sphingomyelin. Data demonstrate that this substrate is internalized through the apolipoprotein B/E receptor pathway and targeted to lysosomes. Lysosomal localization of the incorporated substrate was evidenced by ultrastructural autoradiography and subcellular fractionation as well as by metabolic studies in mutant cells. Short-term pulse-chase experiments with LDL-associated [3H]ceramide-labeled sphingomyelin allowed us to determine the effective activity of lysosomal sphingomyelinase and ceramidase in normal cells. Initial velocities of sphingomyelin and ceramide degradation were, respectively, estimated at 0.66 and 1.14 nmol.h-1.mg cell protein-1 in lymphoid cells, and 5.4 and 3 nmol.h-1.mg cell protein-1 in skin fibroblasts. The advantages and applications of these in situ studies are discussed.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. Loidl, R. Claus, H. P. Deigner, and A. Hermetter High-precision fluorescence assay for sphingomyelinase activity of isolated enzymes and cell lysates J. Lipid Res., May 1, 2002; 43(5): 815 - 823. [Abstract] [Full Text] [PDF]

				J.-P. JAFFREZOU, A. P. BRUNO, A. MOISAND, T. LEVADE, and G. LAURENT Activation of a nuclear sphingomyelinase in radiation-induced apoptosis FASEB J, January 1, 2001; 15(1): 123 - 133. [Abstract] [Full Text] [PDF]

				B. SÉGUI, C. BEZOMBES, E. URO-COSTE, J. A. MEDIN, N. ANDRIEU-ABADIE, N. AUGÉ, A. BROUCHET, G. LAURENT, R. SALVAYRE, J.-P. JAFFRÉZOU, et al. Stress-induced apoptosis is not mediated by endolysosomal ceramide FASEB J, January 1, 2000; 14(1): 36 - 47. [Abstract] [Full Text]